Innovative MedTech Rebrands as AnTix Holdings, Shifts Focus to AI-Powered Ticketing Technology

Innovative MedTech, Inc. has completed its planned corporate rebranding and name change to AnTix Holdings, Inc., marking a significant strategic shift for the company. The change better aligns with the company's new direction as it expands into the growing online ticketing and entertainment technology sector. Michael J. Friedman, President and CEO of AnTix Holdings, Inc., stated that the company sees meaningful opportunities to apply artificial intelligence and Web 3.0 tools to improve the ticketing and live experience for consumers and partners alike.

The company's ticketing technology has already begun generating revenues, providing what management believes will be a strong foundation for the next phase of growth. Friedman emphasized that the company's goal is to build value through innovation, execution and acquisition in a market that is ripe for significant technological change. The transition represents a fundamental shift from the company's previous medical technology focus to the entertainment technology space.

On September 19, 2025, the company filed with the State of Delaware a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to officially change the corporate name from Innovative MedTech, Inc. to AnTix Holdings, Inc. The company's common stock will continue to trade under the ticker symbol IMTH for the time being, though the company intends to file with FINRA to effectuate both the name change and a change to a new ticker symbol. Outstanding stock certificates for shares of the company remain valid and do not need to be exchanged at this time.

AnTix Holdings, Inc. now positions itself as a technology company that delivers artificial intelligence to online ticketing, with a mission to bring transparency, efficiency and personalization to the ticketing and entertainment industry. The company maintains its connection to the medical field through its exclusive licensing agreement for the Oral Thrush application of Shear Kershman Labs' BioViscid™ bio-adhesive encapsulation. More information about the company's new direction and services can be found at https://www.antixholdings.com.

The strategic shift comes at a time when the ticketing industry faces increasing scrutiny over transparency and consumer experience issues. By leveraging artificial intelligence and Web 3.0 technologies, AnTix Holdings aims to address these challenges while capitalizing on the growing demand for improved digital entertainment experiences. The company's move represents a significant pivot that could potentially disrupt traditional ticketing models and create new opportunities in the rapidly evolving entertainment technology landscape.

This corporate transformation signals the company's belief in the substantial growth potential of AI-enhanced ticketing solutions. The entertainment and ticketing industry has shown increasing interest in technological innovations that can streamline operations, enhance security, and improve the overall consumer experience. AnTix Holdings' entry into this space with AI and Web 3.0 capabilities positions the company to potentially capture market share in an industry undergoing digital transformation.